来自MSN11 个月
Antennova Marks Milestone in Cancer Treatment with Promising Early Results from Anti-CD24 ...
The PERFORM trial, led by prestigious institutions including The University of Texas MD Anderson Cancer ... “Introducing the first anti-CD24 program for late-stage cancer patients in the U.S ...